Hairy Cell Leukemia: Towards a Curative Strategy

Keyphrases

• Curative Strategies 100%
• Rituximab 100%
• Hairy Cell Leukemia 100%
• Purine Analogues 100%
• 2-CDA 100%
• BL22 100%
• Monoclonal Antibody 33%
• Standard of Care 33%
• Prolonged Survival 33%
• Interferon-α (IFN-α) 33%
• Dosing Schedule 33%
• Relapsed Disease 33%
• New Agents 33%
• First-line Therapy 33%
• Working Diagnosis 33%
• Highly Active 33%
• Initial Treatment 33%
• Antibody Therapy 33%
• Hematological Response 33%
• Splenectomy 33%
• Previously Untreated 33%
• Salvage Therapy 33%
• Higher CR 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Rituximab 100%
• Purine Derivative 100%
• Purine 100%
• Hairy Cell Leukemia 100%
• Disease 33%
• Monoclonal Antibody 33%
• Interferon 33%